An increased activation of the NF-κB pathway is one of the features of colon cancer development, and the suppression of the NF-κB signaling pathway using nutritional and pharmacological inhibitors is an effective therapeutic approach for the treatment of colon cancer [18]. This evidence concerns the gene NFKB1 and malignant colon neoplasm.